81307

Gene analysis (partner and localizer of brca2) full sequence analysis

Medicare pricing data for 92 providers across 10 states

🤖AI Overview

Note: These costs reflect the Medicare physician/supplier component. Hospital facility fees are billed separately and can be 2-5x the physician fee.

💡 What You Should Know

Gene analysis (partner and localizer of brca2) full sequence analysis (HCPCS code 81307) is a medical procedure billed to Medicare. The average Medicare-allowed cost is $661.45, but hospitals typically charge $803.23 — a 1.2x markup. Prices vary significantly by state and provider.

🏷️ Typical Out-of-Pocket Cost

$132.29

Medicare patients typically pay about 20% of the allowed amount as coinsurance. Based on the average allowed cost of $661.45, your out-of-pocket cost would be approximately $132.29. Actual costs depend on your specific plan, deductible, and whether you've met your annual out-of-pocket maximum.

Average Allowed Cost
$661.45
Average Hospital Charge
$803.23
Markup Ratio
1.2x

What Hospitals Charge vs. What Medicare Pays

Hospital Charge$803.23
Medicare Allowed$661.45
Medicare Payment$661.45

Hospitals charge 1.2x more than what Medicare allows for this procedure. Medicare actually pays $661.45 on average.

Cost by State

Medicare-allowed amounts vary significantly by state

StateAllowed CostHospital ChargeProvidersServicesvs. National
Louisiana$663$9363158+0.2%
Mississippi$663$2,030111+0.2%
New York$663$2,0292555+0.2%
Colorado$663$2,890298+0.2%
Pennsylvania$663$67743,196+0.2%
Texas$662$766279,318+0.1%
Florida$662$7932819,201+0.1%
New Jersey$661$806146,753-0.1%
Oklahoma$660$7933104-0.2%
Maryland$505$8882112-23.7%

⚠️ Important: These costs reflect the Medicare physician/supplier component. Hospital facility fees may be billed separately. Total out-of-pocket costs may be higher.

Related from TheDataProject.ai

💊 Need post-procedure medications? Check costs on OpenPrescriber